Monthly Archives: November 2023

Cardiomyocyte Metabolism Research and Cardiogen Peptide

AoS.Cardiomyocyte Metabolism Research and Cardiogen Peptide

Peptide complex Cardiogen has been hypothesized to function as a bioregulator of cardiovascular function. Fibroblasts, the cells often credited with scar formation and tissue regeneration, are proposed to be the principal targets of Cardiogen in investigations. H-Ala-Glu-Asp-Arg-OH

Naturally occurring peptide may tackle the “root cause” of obesity-related diseases

Obesity typically occurs when a person eats more calories than they need for their daily activity. It results in a build-up of fatty tissue around all organs. In lean people, fat tissues work closely with hormones to

Linking copper, tyrosines and protein aggregation in Alzheimer’s disease

The prevalence of Alzheimer’s disease (AD), the most common cause of dementia nowadays, is expected to increase within the coming years, representing a serious threat for society and the healthcare system. For this reason, a lot of

Improving assessment of arthritis models to better reflect human symptoms of disease

AoS. Improving assessment of arthritis models to better reflect human symptoms of disease

Rheumatoid Arthritis (RA) is a common inflammatory disease that is characterized by swelling and tenderness of multiple joints. The resulting pain and joint stiffness cause disability for patients and treatment to control the inflammation is required to

Systemic therapy in juvenile localized scleroderma

AoS. Systemic therapy in juvenile localized scleroderma

Juvenile localized scleroderma, also known as morphea, is an rare condition, it occurs around 1 in 5000 children, where the skin and the tissues underneath the skin like fat tissue, muscle, tendons, and bone, get inflamed and